First human imaged with novel 3D color x-ray scanner in New Zealand

A 3D color medical scanner invented by father and son scientists in New Zealand recently imaged its first human subject, according to a news release from the University of Canterbury in New Zealand.  

The novel imaging device, called the MARS spectral x-ray scanner, can capture enhanced detail of the body's chemical components—such as fat, water, and disease markers—by measuring the x-ray spectrum to produce images in color. Producing more detailed images than MRI or CT may allow physicians to identify and diagnosis diseases earlier.  

Phil Butler, PhD, a physicist at the University of Canterbury, and his son, Anthony Butler, PhD, a radiology professor at the University of Canterbury and the University of Otago in New Zealand, invented the scanner—and Phil Butler happened to be the first person to be scanned by the MARS spectral x-ray scanner, according to the release. 

“So far researchers have been using a small version of the MARS scanner to study cancer, bone and joint health and vascular diseases that cause heart attacks and strokes," Anthony Butler said in a prepared statement. "In all of these studies, promising early results suggest that when spectral imaging is routinely used in clinics it will enable more accurate diagnosis and personalization of treatment.”

The duo will soon conduct a clinical trial with orthopedic and rheumatology patients to compare the images produced by the MARS spectral x-ray scanner with current imaging technology. 

""

A recent graduate from Dominican University (IL) with a bachelor’s in journalism, Melissa joined TriMed’s Chicago team in 2017 covering all aspects of health imaging. She’s a fan of singing and playing guitar, elephants, a good cup of tea, and her golden retriever Cooper.

Around the web

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease. 

CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. An international group of specialists shared their perspective on this ongoing trend.

The new technology shows early potential to make a significant impact on imaging workflows and patient care.